NetworkNewsBreaks Archive - Page 2028 of 2141

ThursdayJul 13, 2017 11:44 am

NetworkNewsBreaks – American Energy Partners, Inc. (XFUL) Featured in Exclusive Audio Interview by NetworkNewsWire

Multifaceted financial news and publishing company NetworkNewsWire (“NNW”) this morning announced the online availability of an exclusive audio interview with diversified energy company Converde Energy USA (OTC: XFUL), doing business as American Energy Partners, Inc. In the interview, Josh C. Hickman, president of the company’s Gilbert Oil & Gas, LLC, subsidiary, gives listeners insight into XFUL’s corporate history, as well as its ongoing efforts to capitalize on growing markets, such as the market for water ownership. “It is excellent to be in the position that I am with Gilbert and with American Energy Partners,” Hickman noted in the NNW interview.…

ThursdayJul 13, 2017 11:15 am

NetworkNewsBreaks – Moxian, Inc. (NASDAQ: MOXC) Poised to Profit from Forecast 21.5% 2017 Growth in Chinese Digital Advertising

Digital marketing company Moxian, Inc. (NASDAQ: MOXC) is prioritizing meeting its digital advertising revenue goals in light of recent research (http://nnw.fm/eP1LG) that shows digital ad spending in China is soaring to 57.2 percent of total Internet ad spending—up from a mere 19.4 percent just five years ago. A chief aspect of Moxian’s focus is the online-to-offline (O2O) market and helping brick-and-mortar merchants connect with more digitally-oriented customers. “Currently, Moxian is converting its Moxian+ business and user apps from free to paid. Key to Moxian’s revenue stream are fees, subscriptions, licenses and a percentage of all transactions. Vital to this is…

WednesdayJul 12, 2017 2:01 pm

NetworkNewsBreaks – NeuroVive Pharmaceutical AB (NEVPF) Receives Coverage Update, Increased PT by SeeThruEquity

SeeThruEquity has issued a company update and increased price target of SEK 8.50 ($0.98) on shares of NeuroVive Pharmaceutical AB’s (OTCQX: NEVPF) stock. The Sweden-based clinical stage biotechnology company continues to advance its lead candidate, NeuorSTAT® for neuro-protective properties in moderate to severe Traumatic Brain Injury (TBI). The company reported encouraging data from both a study in the U.S. at the University of Pennsylvania, which showed a significantly reduced volume of brain injury, and the CHIC phase 2a clinical trial at Copenhagen University Hospital in Denmark, which met its main objectives of demonstrating safety and characterizing the pharmacokinetic profile of…

WednesdayJul 12, 2017 2:00 pm

NetworkNewsBreaks – SeeThruEquity Issues Update on Great Basin Scientific, Inc. (GBSN)

SeeThruEquity has updated its coverage and issued a price target of $1 on shares of Great Basin Scientific, Inc.’s (OTCQB: GBSN) stock, noting several corporate highlights. Great Basin Scientific has reported growth of over 120% in its pipeline after recently expanding its menu of molecular tests, which the analyst noted also drives opportunity for the company. The planned expansion moves the number of assays to five with a sixth molecular test currently awaiting FDA clearance. For more information, visit www.gbscience.com About Great Basin Scientific Great Basin Scientific is a molecular diagnostics company that commercializes breakthrough chip-based technologies. The company is…

WednesdayJul 12, 2017 1:58 pm

NetworkNewsBreaks – SeeThruEquity Updates Coverage on Q BioMed, Inc. (QBIO)

In a recent update on Q BioMed, Inc. (OTCQB: QBIO), SeeThruEquity noted, among other topics, that the biomedical acceleration and development company’s FDA-approved radiopharmaceutical agent, SR89 (Strontium Chloride), is ahead of schedule and “revenue ready.” Q BioMed has initiated production of SR89 for the treatment of metastatic bone cancer and expects a commercial launch later this year. The company previously estimated it could generate more than $1 million in sales in its first year of commercialization, reaching more than $10 million in sales within 3-5 years. The SeeThruEquity analyst notes that SR89 has the potential for additional indications and a larger therapeutic…

WednesdayJul 12, 2017 12:27 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on July 12, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: CNBX 19.75% – News: Executes final collaboration agreement with SIMFO GmbH TOPS 15.42% – News: Enters two joint venture agreements DMTX 12.50% – News: Chief operating officer joins Enterome SA board LTEA 11.14% – News: Expands local partnerships CNAB 11.08% – News: Approvals from Jamaica's Ministry of Health featured in CFN Media Group publication CRNT 11.07% – News: Reports IP-20 Platform orders of over $9M in Q2 NETE 9.52% – News: Posts update letter…

WednesdayJul 12, 2017 12:06 pm

NetworkNewsBreaks – ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) Lists Common Shares on OTCQB Venture Market and Frankfurt Stock Exchange

ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) this morning announced that its common shares have been approved for trading on the OTCQB Venture Market, under the symbol ‘ABCCF’, and on the Frankfurt Stock Exchange, under the symbol ‘23Q’. The company’s common shares will also continue to trade on the TSX Venture Exchange under the symbol ‘ABCN’. The company expects that these listings will provide a number of long-term benefits, including greater visibility and convenience for investors in the United States and Europe. As a result of this expanded base of potential shareholders, ABcann will likely benefit from enhanced liquidity moving…

WednesdayJul 12, 2017 9:31 am

NetworkNewsBreaks – Net Element, Inc. (NASDAQ: NETE) CEO Issues Letter to Shareholders

Global financial technology and value-added solutions group Net Element, Inc. (NASDAQ: NETE) this morning released an updated letter to shareholders from CEO Oleg Firer. In the update, he recaps the company’s achievements for the first half of the year before taking a look at recent corporate events that could contribute to Net Element’s future performance. “To date, our focus has been on growing our business and creating an efficient, well-functioning company by laying the foundation for a scalable business,” Firer noted in the shareholder letter. “I am pleased to say that we have been successful in the execution of these…

TuesdayJul 11, 2017 1:29 pm

NetworkNewsBreaks – Top 10 Mid-day Percentage Gainers on July 11, 2017

Here is a list of stocks shaking up the markets today, with particular focus on NASDAQ and OTC small caps. The top gainers based on percentage: ITRO 34.62% – News: Reports 35% increase in Q2 2017 GOLD'n GRO zinc fertilizer sales ORHB 19.57% – News: Inks national deployment agreement MRIC 12.25% – News: Posts preliminary Q2 2017 results ENVV 12.20% – News: Retains Hayden IR to implement a strategic investor relations program DATI 7.69% – News: Begins mentorship OpenVision Labs MIHI 5.45% – News: Reaches a definitive agreement with Renaissance Health Publishing, LLC XBIT 4.70% – News: Law firm files…

TuesdayJul 11, 2017 12:57 pm

NetworkNewsBreaks – Cascadian Therapeutics, Inc. (NASDAQ: CASC) Reports Positive Regulatory Update for Tucatinib in Europe Following EMA Discussion

Cascadian Therapeutics (NASDAQ: CASC) this morning reported a positive outcome from recent discussions with the European Medicines Agency (EMA) regarding the development of the company’s investigational medicine for the treatment of HER2-positive metastatic breast cancer, tucatinib. The company has received validating news that if the ongoing pivotal trial of tucatinib known as HER2CLIMB demonstrates positive results, it could serve as a single registrational trial for submission of a Marketing Authorization Application (MAA) to the EMA and potential marketing approval. Cascadian received a similar confirmation from the FDA last year. “This is an important milestone for the company. We had anticipated…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks